WO2025173034 - HYALURONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE
National phase entry is expected:
Publication Number
WO/2025/173034
Publication Date
21.08.2025
International Application No.
PCT/IN2025/050206
International Filing Date
13.02.2025
Title **
[English]
HYALURONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE
[French]
DÉRIVÉS D'ACIDE HYALURONIQUE ET LEUR UTILISATION THÉRAPEUTIQUE
Applicants **
ZYDUS LIFESCIENCES LIMITED
Inventors
DESAI, Ranjit
MITTAL, Ravindra
PANDYA, Vrajesh
JOHARAPURKAR, Amit Arvind
PUJARA, Mehul
VORA, Bhavesh
Priority Data
202421010112
14.02.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2182 | |
| EPO | Filing, Examination, Granting | 11887 | |
| Japan | Filing, Examination, Granting | 2178 | |
| South Korea | Filing, Examination, Granting | 2107 | |
| USA | Filing, Examination, Granting | 9540 |
Total:
27,894
Contact Us
Abstract[English]
The present invention relates to hyaluronic acid derivatives of the general formula (I) to which anti-inflammatory or disease-modifying drug is attached through a biodegradable linker to treat chronic degenerative diseases such as osteoarthritis or related inflammatory disorders, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.[French]
La présente invention concerne des dérivés d'acide hyaluronique de formule générale (I) dans laquelle un médicament anti-inflammatoire ou modificateur de maladie est fixé par l'intermédiaire d'un lieur biodégradable pour traiter des maladies dégénératives chroniques telles que l'arthrose ou des troubles inflammatoires associés, leurs sels pharmaceutiquement acceptables, des compositions pharmaceutiques les contenant, des procédés pour leur préparation, l'utilisation de ces composés en médecine et les intermédiaires impliqués dans leur préparation.